Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (51-60 of 484) with videos related to

Pageof 49
Sort By:
Lancet (London, England)|November 10, 1979
Cosmetic talc and ovarian cancerD L Longo, R C Young
Seminars in Oncology|June 1, 1987
Use of serum tumor markers in cancer diagnosis and managementS E Bates, D L Longo
Journal of Interferon Research|August 1, 1994
Clinical relevance of recombinant interferon-alpha 2a antibodies in patients with hairy cell leukemiaR G Steis, D L Longo
Journal of the National Cancer Institute|August 5, 1992
Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2W J Murphy, D L Longo
Comprehensive Therapy|November 1, 1977
Evaluation of suspected thyroid dysfunctionD L Longo, P R Larsen
Cancer Research|September 1, 1985
Clinical spectrum of human retroviral-induced diseasesW J Urba, D L Longo
Immunological Reviews|June 1, 1997
The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantationW J Murphy, D L Longo
Survey of Immunologic Research|January 1, 1985
Acquisition of MHC-restriction specificities: role of thymic stromal cellsA M Kruisbeek, D L Longo
Seminars in Oncology|December 1, 1986
Alpha-interferon in the treatment of nodular lymphomasW J Urba, D L Longo
Annual Review of Medicine|January 1, 1981
The natural history and treatment of ovarian cancerD L Longo, R C Young
Pageof 49

Showing results (51-60 of 484) with videos related to

Sort By:
Pageof 49
Lancet (London, England)|November 10, 1979
Cosmetic talc and ovarian cancerD L Longo, R C Young
Seminars in Oncology|June 1, 1987
Use of serum tumor markers in cancer diagnosis and managementS E Bates, D L Longo
Journal of Interferon Research|August 1, 1994
Clinical relevance of recombinant interferon-alpha 2a antibodies in patients with hairy cell leukemiaR G Steis, D L Longo
Journal of the National Cancer Institute|August 5, 1992
Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2W J Murphy, D L Longo
Comprehensive Therapy|November 1, 1977
Evaluation of suspected thyroid dysfunctionD L Longo, P R Larsen
Cancer Research|September 1, 1985
Clinical spectrum of human retroviral-induced diseasesW J Urba, D L Longo
Immunological Reviews|June 1, 1997
The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantationW J Murphy, D L Longo
Survey of Immunologic Research|January 1, 1985
Acquisition of MHC-restriction specificities: role of thymic stromal cellsA M Kruisbeek, D L Longo
Seminars in Oncology|December 1, 1986
Alpha-interferon in the treatment of nodular lymphomasW J Urba, D L Longo
Annual Review of Medicine|January 1, 1981
The natural history and treatment of ovarian cancerD L Longo, R C Young
Pageof 49